Effect of various factors on ejaculate fertility in vitro

Author:

Evdokimov V. V.1ORCID,Isaev N. K.2ORCID,Turovetskiy V. B.2

Affiliation:

1. N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Center of Radiology, Ministry of Health of Russia

2. Faculty of Biology, Lomonosov Moscow State University

Abstract

Introduction. Current demographic situation in Russia is characterized by decreasing birth rate. According to the World Health Organization, percentage of child-free marriages in various countries is 10–15 %. In Russia, the National Medical Research Center for Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov states that this number is 17 %. More than 4 million men suffer from infertility of various types. In recent years, pathologies of male reproductive function have achieved medical and social significance due to progressively decreasing sperm fertility. Fertility disorders are considered multi-factor conditions caused by internal and external factors and leading to pathological changes in sex organs. Correction of pathologies of male fertility does not always lead to positive results. Therefore, it is important to develop and study effective pharmaceuticals affecting the main fertility parameters.The study objective is to investigate the effect of various biological pharmaceuticals, physical and chemical factors on parameters of ejaculate fertility in vitro.Materials and methods. Experiments with a protein-peptide complex (PPC), methylene blue, and hydrogen peroxide were performed on human semen. After semen dilution, the sample was studied under the microscope and sperm motility and other ejaculate parameters were evaluated per the 5th edition WHO standard. Experiments were performed at 20–22 ºС. Statistical data analysis was performed using the Student’s t-test. Differences were considered statistically significant at р <0.05.Results. The results show increased motility in the fraction of active motile sperm in first 30 minutes after incubation with methylene blue. In case of initial asthenospermia, active motility increased by 72 %, in case of normospermia by 89 %. After 2 hours, all motility fractions were at the baseline level.The experiments also showed significant changes in sperm motility in the presence of PPC preparation in the ejaculate: increase in sperm motility was observed beginning at 30-minute mark and this level persisted through 3 hours of observation. A more pronounced change, by 60 %, was observed in the active motile sperm; total motility increased by up to 30 %. After 24 hours, sperm motility remained close to the baseline level, the number of normal sperm forms and live cells did not change. Dependence of the motility change on the preparation concentration should be noted: the highest increase was observed at PPC concentration with total protein level of 10–12 mg/mL. Higher concentrations did not have a positive effect on sperm motility. In experiments with low hydrogen peroxide concentration, a positive effect on sperm motility was observed.Conclusions. Sperm motility is supported by glycolysis energy, and one of the glycolysis enzymes glyceraldehyde 3-phosphate dehydrogenase is tightly bound to the fibrous layer of the flagellum, activation of metabolic pathways leading to increased enzyme activity, increased sperm motility. The mechanism of the observed effect is not entirely clear, however, the obtained data demonstrate potential benefits of further studies on use of pharmaceuticals in andrological and reproductive practice, assisted reproductive technologies, as well as for stimulation of sperm motility in further experimental studies.

Publisher

Publishing House ABV Press

Subject

Urology,Reproductive Medicine,Surgery

Reference16 articles.

1. Andrologiya. Klinicheskie rekomendatsii. Pod red. P.A. Shchepleva. M.: Medpraktika, 2012. 155 s. [Andrology. Clinical guidelines. Ed. by P.A. Shcheplev. Moscow: Medpraktika, 2012. 155 p. (In Russ.)].

2. Andrologiya. Muzhskoe zdorov'e i disfunktsiya reproduktivnoi sistemy. Pod red. E. Nishlaga, G.M. Bere. M.: Meditsinskoe informatsionnoe agentstvo, 2005. 554 s. [Andrology. Male health and reproductive dysfunction. Ed. by: E. Nishlag, G.M. Bere. Moscow: Meditsinskoe informatsionnoe agentstvo, 2005. 554 p. (In Russ.)].

3. Pashkova E.Yu., Kalinchenko S.Yu. Muzhskoe besplodie v KhKhI veke – realii i perspektivy. Novye vozmozhnosti ispol'zovaniya kombinirovannoi stimuliruyushchei terapii gonadotropinami. Effektivnaya farmakoterapiya 2013;1:26–31. [Pashkova E.Yu., Kalinchenko S.Yu. Male infertility in the 21st century – realities and prospects. New possibilities for using gonadotropin combination stimulatory therapy. Effektivnaya farmakoterapiya = Effective pharmacotherapy 2013;1:26–31. (In Russ.)].

4. Bykov V.L. Spermatogenez u muzhchin v kontse KhKh veka (obzor literatury). Problemy reproduktsii 2000;6(1):6–13. [Bykov V.L. Spermatogenesis in men in the late twentieth century (literature review). Problemy reproduktsii = Russian Journal of Human Reproduction 2000;6(1):6–13. (In Russ.)].

5. Rozhdaemost' i planirovanie sem'i v Rossii: Istoriya i perspektivy. Pod red. I.A. Troitskoi, A.A. Avdeeva Sb. st. Ser. Demograficheskie issledovaniya. Vyp. 18. M.: TEIS, 2011. S. 177. [Fertility and family planning in Russia: History and perspectives. Ed. by I.A. Troitskaya, A.A. Avdeev. Coll. Articles. Ser. Demographic research. Issue 18. Moscow: TEIS, 2011. p. 177. (In Russ.)].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3